GX CC2 Pill - tan capsule/oblong
Generic Name: amprenavir
Pill with imprint GX CC2 is Tan, Capsule/Oblong and has been identified as Agenerase 150 MG. It is supplied by GSK Pharm.
Agenerase is used in the treatment of HIV Infection and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Agenerase 150 MG is not a controlled substance under the Controlled Substances Act (CSA).
Images for GX CC2
Agenerase
- Generic Name
- amprenavir
- Imprint
- GX CC2
- Strength
- 150 MG
- Color
- Tan
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GSK Pharm
- National Drug Code (NDC)
- 00173-0672 (Discontinued)
See also:
Biktarvy
Biktarvy is a complete HIV-1 treatment in a once-a-day single tablet containing three antiviral ...
Descovy
Descovy is used to treat and prevent HIV infection in adults and adolescents. When used for HIV-1 ...
Cabenuva
Cabenuva (cabotegravir and rilpivirine) injections are a long-acting HIV treatment used to keep HIV ...
Truvada
Truvada is used to prevent HIV (HIV PrEP) or treat HIV-1 infection in combination with other HIV-1 ...
Atripla
Atripla prevents the human immunodeficiency virus (HIV) from reproducing in your body. Learn about ...
Complera
Complera (emtricitabine, rilpivirine, and tenofovir) is used to treat HIV infection. Includes ...
Stribild
Stribild (cobicistat, elvitegravir, emtricitabine and tenofovir) is used to treat HIV-1 infection ...
Epzicom
Epzicom is used to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). Learn ...
Emtricitabine
Emtricitabine is used for HIV Infection, nonoccupational exposure, occupational exposure
More about Agenerase (amprenavir)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: protease inhibitors
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.